Monday, May 25, 2026 Sign InRegister FREE My Account Help
Opinion

[Press release] AbbVie announces positive CHMP opinion for MAVIRET® (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C infection – European AIDS Treatment Group

[Press release] AbbVie announces positive CHMP opinion for MAVIRET® (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C infection  European AIDS Treatment Group

COMMENTS (0)

Leave a Comment